Y Intercept (Hong Kong) LTD I Teos Therapeutics, Inc. Transaction History

Y Intercept (Hong Kong) LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$10.33 - $18.09 $215,008 - $376,525	20,814 New	20,814 $308,000
Q4 2023 Feb 13, 2024	SELL	$8.57 - $11.06 $42 - $55	-5 Reduced 0.02%	26,430 $289,000
Q3 2023 Nov 14, 2023	BUY	$10.95 - $14.6 $289,463 - $385,951	26,435 New	26,435 $289,000
Q1 2023 May 09, 2023	BUY	$13.02 - $22.62 $6,952 - $12,079	534 Added 4.1%	13,573 $184,000
Q4 2022 Feb 14, 2023	BUY	$17.77 - $21.6 $231,703 - $281,642	13,039 New	13,039 $254,000

165

36.6M

1.95M

374K

Ticker ITOS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,575,300
Market Cap $293M
Description
Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.